---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-010687"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-06-02T23:59:59+00:00"
generated_at: "2026-05-20T03:22:51.909590+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma prices $7M public offering of 2.26M units at $3.10/unit; closes June 2

## Summary
- Gross proceeds $7,006,000 from 2,260,000 units at $3.10/unit; each unit = 1 common share + 1 warrant.
- Warrants exercisable at $3.10/share, expire 5 years from issuance; not listed on exchange.
- Net proceeds to fund Phase 2 proof-of-concept trial for basal cell carcinoma using doxorubicin tip loaded dissolvable microarray needle skinpatch.
- Co. also issued $1.25M second-tranche debenture to Yorkville on June 2, 2025, bringing total Yorkville debentures to $2.5M.
- Placement agents Maxim, Brookline, D. Boral; cash fee 7.5% of gross proceeds.

## SEC filing metadata
- accession: 0001062993-25-010687
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325010687/0001062993-25-010687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325010687/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-010687
- JSON: https://secwatch.observer/filing/0001062993-25-010687.json
- Plain text: https://secwatch.observer/filing/0001062993-25-010687.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.